PROFUND ADVISORS LLC

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1129919 BETHESDA, MD

Position in CLDX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,076,485

+$139,921 QoQ

Shares Held

28,930

-2.0% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#121

of 252 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. CLDX ranks #59 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,076,485	28,930	-2.0%	Shares	Sole	2026-08-11
2026-03-31	$936,564	29,526	-30.5%	Shares	Sole	2026-04-27
2025-12-31	$1,153,050	42,454	+99.3%	Shares	Sole	2026-02-06
2025-09-30	$551,160	21,305	+38.1%	Shares	Sole	2025-11-06
2025-06-30	$313,898	15,425	-31.9%	Shares	Sole	2025-08-07
2025-03-31	$411,006	22,645	-23.1%	Shares	Sole	2025-05-08
2024-12-31	$743,797	29,434	+58.6%	Shares	Sole	2025-02-14
2024-09-30	$630,888	18,561	-17.5%	Shares	Sole	2024-11-14
2024-06-30	$832,947	22,506	-25.8%	Shares	Sole	2024-08-13
2024-03-31	$1,273,663	30,347	+23.9%	Shares	Sole	2024-05-08
2023-12-31	$971,114	24,486	-12.7%	Shares	Sole	2024-02-14
2023-09-30	$771,633	28,039	-25.1%	Shares	Sole	2023-11-13
2023-06-30	$1,269,694	37,421	+36.7%	Shares	Sole	2023-08-10
2023-03-31	$984,844	27,372	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.